Fluorescence-based viability assay for studies of reactive drug intermediates☆
References (20)
- et al.
Blood
(1983) - et al.
J. Pediatr
(1977) - et al.
J. Immunol. Methods
(1984) - et al.
J. Immunol. Methods
(1984) - et al.
J. Immunol. Methods
(1987) - et al.
N. Engl. J. Med
(1981) - et al.
Lancet
(1985) - et al.
Ann. Int. Med
(1986) - et al.
J. Pharmacol. Exp. Ther
(1988) - Glatt, H., Kaltenbach, E., and Oesch, F. Cancer Res.40,...
There are more references available in the full text version of this article.
Cited by (36)
Development of a high volume screen to identify inhibitors of endothelial cell activation
1996, Analytical BiochemistryThe effect of carbamazepine and its reactive metabolite, 9-acridine carboxaldehyde, on immune cell function in vitro
1995, International Journal of ImmunopharmacologyTime-course of toxicity of reactive sulfonamide metabolites
1995, ToxicologyCARE-LASS (calcein-release-assay), an improved fluorescence-based test system to measure cytotoxic T lymphocyte activity
1994, Journal of Immunological Methods
- ☆
This work was Supported by grants to HMD and SPS from the Medical Research Council, the National Cancer Institute, and the Muscular Dystrophy Foundation of Canada.
- 2
JSL is supported by a fellowship from the Medical Research Council of Canada.
- 3
SPS is a Scholar of the Medical Research Coucil of Canada.
Copyright © 1989 Published by Elsevier Inc.